| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |